Back to Results
First PageMeta Content
Integrase inhibitors / Organofluorides / Chemistry / Azides / Zidovudine / AIDS / Antiretroviral drug / GlaxoSmithKline / ViiV Healthcare / HIV/AIDS / Health / Medicine


For Immediate Release ViiV Healthcare receives approval for Tivicay™ (dolutegravir) in
Add to Reading List

Document Date: 2013-11-04 16:34:44

Open Document

File Size: 307,68 KB

Share Result on Facebook

City

Hamilton / Edmonton / Tivicay / Vancouver / Toronto / Winnipeg / Calgary / Montreal / Ottawa / /

Company

Pfizer / GlaxoSmithKline / HIV/AIDS / Shionogi / Healthcare ViiV Healthcare / /

Continent

North America / /

Country

Canada / /

/

Event

M&A / /

Facility

ViiV Healthcare pipeline / /

IndustryTerm

HIV treatment / treatment of HIV / healthcare / food / /

MedicalCondition

complicated and devastating disease / HIV / disease / chronic disease / AIDS / infection / /

Organization

Government of Canada / /

Person

Gregory Reinaud / John Pottage / Marlo Taylor / /

/

Position

General Manager / Chief Medical Officer / ViiV Healthcare / /

Technology

pharmacokinetics / /

URL

http /

SocialTag